NGM BIOPHARMACEUTICALS INC - FORM S-1 - EX-23.1 - September 28, 2018

Attached files

file filename
S-1 - S-1 - NGM BIOPHARMACEUTICALS INCd693178ds1.htm
EX-10.2 - EX-10.2 - NGM BIOPHARMACEUTICALS INCd693178dex102.htm
EX-10.11 - EX-10.11 - NGM BIOPHARMACEUTICALS INCd693178dex1011.htm
EX-3.1 - EX-3.1 - NGM BIOPHARMACEUTICALS INCd693178dex31.htm
EX-4.1 - EX-4.1 - NGM BIOPHARMACEUTICALS INCd693178dex41.htm
EX-10.13 - EX-10.13 - NGM BIOPHARMACEUTICALS INCd693178dex1013.htm
EX-10.7 - EX-10.7 - NGM BIOPHARMACEUTICALS INCd693178dex107.htm
EX-10.9 - EX-10.9 - NGM BIOPHARMACEUTICALS INCd693178dex109.htm
EX-3.4 - EX-3.4 - NGM BIOPHARMACEUTICALS INCd693178dex34.htm
EX-10.18 - EX-10.18 - NGM BIOPHARMACEUTICALS INCd693178dex1018.htm
EX-10.15 - EX-10.15 - NGM BIOPHARMACEUTICALS INCd693178dex1015.htm
EX-10.17 - EX-10.17 - NGM BIOPHARMACEUTICALS INCd693178dex1017.htm
EX-10.16 - EX-10.16 - NGM BIOPHARMACEUTICALS INCd693178dex1016.htm
EX-3.3 - EX-3.3 - NGM BIOPHARMACEUTICALS INCd693178dex33.htm
EX-10.14 - EX-10.14 - NGM BIOPHARMACEUTICALS INCd693178dex1014.htm
EX-10.12 - EX-10.12 - NGM BIOPHARMACEUTICALS INCd693178dex1012.htm
EX-10.1 - EX-10.1 - NGM BIOPHARMACEUTICALS INCd693178dex101.htm
EX-10.19 - EX-10.19 - NGM BIOPHARMACEUTICALS INCd693178dex1019.htm
EX-10.10 - EX-10.10 - NGM BIOPHARMACEUTICALS INCd693178dex1010.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 10, 2018, in the Registration Statement (Form S-1) and related Prospectus of NGM Biopharmaceuticals, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Redwood City, California

September 28, 2018

NGM BIOPHARMACEUTICALS INC Reports